Basic Information of SLC19A2 | |
Protein Name | Thiamine transporter 1 (ThTr1) |
Gene Name | SLC19A2 |
Aliases | Solute carrier family 19 member 2,Thiamine carrier 1(TC1) |
Organism | Homo sapiens (Human) |
UniProt ID | O60779 |
Transmembrane Times | 12 |
Length (aa) | 497 |
Sequence | MDVPGPVSRRAAAAAATVLLRTARVRRECWFLPTALLCAYGFFASLRPSEPFLTPYLLGPDKNLTEREVFNEIYPVWTYSYLVLLFPVFLATDYLRYKPVVLLQGLSLIVTWFMLLYAQGLLAIQFLEFFYGIATATEIAYYSYIYSVVDLGMYQKVTSYCRSATLVGFTVGSVLGQILVSVAGWSLFSLNVISLTCVSVAFAVAWFLPMPQKSLFFHHIPSTCQRVNGIKVQNGGIVTDTPASNHLPGWEDIESKIPLNMEEPPVEEPEPKPDRLLVLKVLWNDFLMCYSSRPLLCWSVWWALSTCGYFQVVNYTQGLWEKVMPSRYAAIYNGGVEAVSTLLGAVAVFAVGYIKISWSTWGEMTLSLFSLLIAAAVYIMDTVGNIWVCYASYVVFRIIYMLLITIATFQIAANLSMERYALVFGVNTFIALALQTLLTLIVVDASGLGLEITTQFLIYASYFALIAVVFLASGAVSVMKKCRKLEDPQSSSQVTTS |
Mutations in SLC19A2 result in thiamine-responsive giant cell anemia syndrome (TRMA), an autosomal recessive disorder characterized by diabetes, giant cell anemia, and sensorineural deafness. TRMA was confirmed in the mutation of SLC19A2. A homozygous splicing site was detected in the SLC19A2 gene. A mutation in the SLC19A2 gene, which encodes the thiamine transporter transporter 1 (THTR1), is associated with TRMA. Despite the need to take thiamine for life to improve blood and endocrine diseases, it does not respond to neurological symptoms including hearing loss.
Fig.1 The structure of SLC19A2 Protein.
The report indicates that SLC19A2 is not limited to blood relatives or apartheid families, but should be considered a differential diagnosis of patients with clinical symptoms.
The authors recommend that more research be needed to clarify any link between SLC19A2 and stroke as a result of this disease.
This article suggests that administration of thiamine improves macrophage anemia and hyperglycemia in patients with SLC19A2.
This study suggests that this effect is regulated to some extent by the transcriptional machinery (s), affecting the SLC19A2 and SLC19A3 genes.
These results indicate that the DNA methylation level of SLC19A2 is affected by SNPs of FV Leiden.
To obtain the soluble and functional target protein, the versatile Magic™ membrane protein production platform in Creative Biolabs enables many flexible options, from which you can always find a better match for your particular project. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-SLC19A2 antibody development services.
Creative Biolabs' skillful scientists are glad to leverage our expertise and advanced technologies to help you with the member protein research. If you are interested, please feel free to contact us for more details.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.